Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)

7.62
Delayed Data
As of 3:26pm ET
 0.00 / 0.00%
Today’s Change
5.02
Today|||52-Week Range
13.30
-9.39%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Bellicum Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 23.00 and a low estimate of 14.00. The median estimate represents a +149.34% increase from the last price of 7.62.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Bellicum Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.55
Sales
$87.6K
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 18.69%
 
 
 
 
 
 
Growthannually 17.98%
 
 
 
 
 
 

Sales

Growthquarterly -43.12%
 
 
 
 
 
 
Growthannually 579.91%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.